Celgene Thalidomide Trademark Details

Celgene Thalidomide was registered on Tuesday, June 9, 2009 and is currently owned by Celgene Corporation under the registration number 3634457 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 8 years ago on Friday, January 15, 2016, according to the United State Patent & Trademark Office
Word Mark Celgene Thalidomide
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Celgene Corporation of Summit, NJ

View all trademarks for Celgene Corporation
Other Trademarks for Celgene Corporation
Serial Number 77586151
Registration Number 3634457
Status Date Friday, January 15, 2016
Filing Date Friday, January 15, 2016
Registration Date Tuesday, June 9, 2009
Attorney Camille M. Miller

Correspondent

CAMILLE M. MILLER
COZEN O'CONNOR, PC
One Liberty Place
1650 MARKET ST
PHILADELPHIA PA 19103-3508

Case File Statements

Disclaimer with Predetermined Text "Thalidomide"
Goods & Services Pharmaceutical Preparations Used to Treat Cancers and Immune Related Diseases

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, January 15, 2016
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.